CYTOSORBENTS CORPORATION Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CYTOSORBENTS CORPORATION stock issued during period, value, stock options exercised for the quarter ending 2021-12-31 was -$1.00.
- CYTOSORBENTS CORPORATION stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $0.00.
- CYTOSORBENTS CORPORATION stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was -$2.83K.
- CYTOSORBENTS CORPORATION stock issued during period, value, stock options exercised for the quarter ending 2021-03-31 was $0.00.
- CYTOSORBENTS CORPORATION stock issued during period, value, stock options exercised for fiscal 2021 was -$2.83K.
- CYTOSORBENTS CORPORATION stock issued during period, value, stock options exercised for fiscal 2020 was $0.00.
- CYTOSORBENTS CORPORATION stock issued during period, value, stock options exercised for fiscal 2019 was $0.00.
- CYTOSORBENTS CORPORATION stock issued during period, value, stock options exercised for fiscal 2018 was $0.00.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2021-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$2.83K 10-K · filed 2024-03-15 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-04 | -$2.83K derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-06-30 | -$2.83K 10-Q · filed 2022-08-02 | -$2.83K derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-03 | $0.00 derived: sum of 4 quarters · filed 2022-05-03 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $0.00 10-K · filed 2022-03-10 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-04 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $0.00 10-K · filed 2022-03-10 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $0.00 derived: sum of 4 quarters · filed 2021-03-09 |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-04 | $0.00 derived: sum of 4 quarters · filed 2021-03-09 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-05 | $0.00 derived: sum of 4 quarters · filed 2021-03-09 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $0.00 10-K · filed 2021-03-09 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-05 | $0.00 derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $0.00 derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-07 | $0.00 derived: sum of 4 quarters · filed 2020-03-05 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $0.00 10-K · filed 2020-03-05 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-08 | |
| 2015-12-31 | $0.00 10-K · filed 2018-03-08 | |
| 2014-12-31 | -$90.86K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $0.00 10-K · filed 2017-03-03 |
| 2014-09-30 | $29.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $90.86K derived: sum of 4 quarters · filed 2015-03-31 |
| 2014-06-30 | $9.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $66.20K derived: sum of 4 quarters · filed 2015-03-31 |
| 2014-03-31 | $51.76K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $20.19K 10-K · filed 2015-03-31 |
| 2013-09-30 | $5.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | |
| 2012-12-31 | $10.61K 10-K · filed 2014-03-31 | |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $5.14K 10-K · filed 2014-03-31 |
| 2011-09-30 | $2.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |